The first company using precision medicine and companion diagnostics to create new therapeutics for GI and immune-mediated diseases
Prometheus 360™ Precision Medicines Platform
The world’s largest GI biobank—with corresponding longitudinal clinical records —to identify novel drug targets for treating GI patients
Best in Class Therapeutics Pipeline
A broad portfolio of precision therapeutics to meet the unmet medical needs of those living with GI diseases
Strategic Collaborations & Partnerships
Partnerships with pharmaceutical companies, foundations, and academic groups with critical GI area expertise and resources
Experienced Team
Management, Board of Directors and Scientific Advisors are comprised of world class GI & autoimmune experts